LifeMD, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US53216B1044
USD
3.73
0.17 (4.78%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Pediatrix Medical Group, Inc.
Talkspace, Inc.
Enhabit, Inc.
Hims & Hers Health, Inc.
The Pennant Group, Inc.
LifeMD, Inc.
Fulgent Genetics, Inc.
OPKO Health, Inc.
CareMax, Inc.
DocGo, Inc.
Celldex Therapeutics, Inc.
Why is LifeMD, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Operating profit has grown by an annual rate 11.30% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -23.04
2
The company has declared Positive results for the last 4 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD 19.48 MM
  • NET SALES(HY) At USD 127.92 MM has Grown at 34.92%
  • NET PROFIT(HY) Higher at USD -0.69 MM
3
Risky - Negative Operating Profits
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -39.26%, its profits have risen by 51.7%
4
High Institutional Holdings at 53.14%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
5
Below par performance in long term as well as near term
  • Along with generating -39.26% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to LifeMD, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is LifeMD, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
LifeMD, Inc.
-39.45%
-0.47
102.14%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
64.36%
EBIT Growth (5y)
11.30%
EBIT to Interest (avg)
-23.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
6.65
Sales to Capital Employed (avg)
15.80
Tax Ratio
4.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.14%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-248.81
EV to EBIT
-75.89
EV to EBITDA
215.33
EV to Capital Employed
-31.66
EV to Sales
2.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD 19.48 MM

NET SALES(HY)

At USD 127.92 MM has Grown at 34.92%

NET PROFIT(HY)

Higher at USD -0.69 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 15.98 times

-1What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 795.23 %

Here's what is working for LifeMD, Inc.
Net Profit
At USD -0.69 MM has Grown at 94.94%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Operating Cash Flow
Highest at USD 19.48 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Sales
At USD 127.92 MM has Grown at 34.92%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Net Profit
Higher at USD -0.69 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 15.98 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation
Highest at USD 2.82 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for LifeMD, Inc.
Debt-Equity Ratio
Highest at 795.23 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio